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The  process  by  which  viruses  destabilize  endosomal 
membranes  in an acidification-dependent  manner  has 
been  mimicked  with  synthetic  peptides  that  are  able  to 
disrupt liposomes, erythrocytes, or endosomes of cul- 
tured  cells.  Peptides  containing  the 20 amino-terminal 
amino  acid  sequence  of iduenza virus  hemagglutinin 
as well as acidic  derivatives  showed  erythrocyte  lysis 
activity  only  when  peptides  were  elongated  by  an  am- 
phipathic helix or by carboxyl-terminal dimerization. 
Interestingly,  peptides  consisting  of  the 23 amino-termi- 
nal  amino  acids  of  influenza  virus  hemagglutinin  were 
also  active  in  erythrocyte  lysis. When peptides  were  in- 
corporated  into DNA complexes  that  utilize  a  receptor- 
mediated  endocytosis  pathway  for  uptake  into  cultured 
cells,  either by ionic  interaction  with  positively  charged 
polylysine-DNA complexes or by a  streptavidin-biotin 
bridge,  a  strong  correlation  between  pH-specific  eryth- 
rocyte disruption activity and gene transfer was ob- 
served. A high-level  expression of luciferase or interleu- 
kin-2 was  obtained  with  optimized  gene  transfer 
complexes in human melanoma cells and several cell 
lines. 
One limiting  step  to  receptor-mediated  gene  delivery (1-3) is 
the exit of DNA from endosomes (4-6). We have previously 
generated  synthetic  complexes that mimic  the  entry of viruses 
into cells (7, 8). These  complexes  contain a ligand  for  endocy- 
tosis into  the target cell and a membrane-destabilizing  function 
for  entry  into the cytoplasm.  They  consist of plasmid  DNA, a 
polylysine-conjugated  ligand  (transferrin or a synthetic  ligand 
binding to the asialoglycoprotein  receptor), and polylysine-con- 
jugated  peptides  derived  from  the  amino-terminal  sequence of
influenza virus hemagglutinin HA-2. The influenza  peptides 
were  found  to  substantially  augment  (up  to >500-fold) receptor- 
mediated  gene  transfer  in a series of cell  lines. Triggered by an 
acidic  environment, the peptides  can  disrupt  liposomes (7,  9). 
This is consistent  with  our  working  hypothesis that the endo- 
some-disruptive  properties of these peptides  are  responsible  for 
the  enhanced  gene  expression. In this communication,  we ad- 
dress the question of whether  influenza  virus-derived  peptides 
are able  to  disrupt  endosomes of living  cells. We present  new 
peptide  derivatives with pH-specific, increased  membrane dis- 
ruption  activity  and  describe their use in a modified  version of 
the gene transfer system. The influence of the peptide se- 
quences and organization of the DNA  complex on  membrane 
disruption  and gene transfer has been investigated. 
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EXPERIMENTAL PROCEDURES 
Materials 
The plasmid pCMVL,  coding for the Photinus pyralis luciferase gene, 
has been described in Ref. 8. Streptavidin-poly-L-lysine conjugates and 
human transferrin-poly-L-lysine conjugates Tf‘pLysm  were prepared as 
reported (6, 10). Conjugates contained streptavidin and pLysZw at a 
molar ratio of 3.5:l. Electroneutral DNAcomplexes are obtained with 4 
pg of TfpLysZgo  (i.e. 4 pg of transferrin conjugated to 2 pg of polylysine, 
calculated as hydrobromide salt) and 3 pg of  DNA. 
Peptide  Synthesis 
Peptides were assembled on an Applied  Biosystems  431A synthesizer 
by using p-alkoxybenzylalcohol resin (Bachem, 0.97 mmoug) as solid 
support and Fmocl-protected  amino acids (Bachem). Amino acids were 
coupled  by the HBTU activation method (11) or by the standard  Fmod 
HOBT chemistry (12). The following protecting groups were used: 
(Trt)Asn, (Trt)Cys or (t-Bu)Cys, (t-Bu)Glu, (Trt)His, (t-Bu)Ser. The pep- 
tides were  cleaved  from the resin, and the side chain protecting groups 
were  removed  (except (t-Bu)Cys) with trifluoroacetic acid/water/phenol/ 
thioanisol/ethanedithiol(10:0.5:0.75:0.5:0.25). Crude peptides were pre- 
cipitated by dropwise addition of ether and were  collected by centrifu- 
gation. Peptides were  washed three times with ether  and subsequently 
dried under a stream of argon  followed by high vacuum. 
Peptides INFl to INF4,  INF6, INF74rude  peptides were  dissolved 
in 1 ml of 20 mM ammonium bicarbonate, pH 8, containing 10 pl of 
P-mercaptoethanol. The solution was subjected to gel filtration (Seph- 
adex G-10, HBS, pH 7.3). The pooled peptide fractions were diluted 
2-fold with water and loaded  onto a Mono Q column (Pharmacia LKB 
Biotechnology Inc. HR 5/5;  buffer A 20 m~ HEPES, pH  7.3;  buffer B: A 
plus 3 M NaC1; gradient elution 0.3  ml/min, 0-50% B in 30 min; peptides 
were eluted at 0.6-0.8 M NaCI). Biotinylated INF3 was obtained by 
addition of 0.2 m o l  of biotin-maleimide (Sigma; 10 m~ in dimethylfor- 
mamide) to  0.2 pmol of INF3 (mercapto form) in 80 l.11 of HBS. The 
reaction was complete within a few seconds as judged by qualitative 
Ellman’s assay (13). The reaction mixture was subjected to gel filtration 
on Sephadex G-10, with 20 m~ HEPES, pH  7.3, as eluent. 
Dimeric Peptides INF3DI and INF4DI-The mercapto form of the 
peptide (approximately 0.5 pmoVml in 0.8 M NaC1,  20 m~ HEPES, pH 
7.3) was reacted with 10 eq of 2,2’-dithiobispyridine (10 m~ in ethanol) 
at room temperature overnight. Excess reagent was removed by gel 
filtration (Sephadex G-10,  HBS)  to obtain the (2-pyridylthio)-Cys pep- 
tides. Dimeric peptides were prepared by mixing equimolar amounts of 
the pyridylthio-modified peptide with the mercapto form of peptide in 1 
M NaCI,  20 m~ HEPES, pH 7.3, concentrating to  half of the original 
volume  by evaporation in a Speed Vac (Savant)  and reaction overnight. 
The resulting material was desalted (Sephadex G-10,  HBS) and finally 
purified by  ion exchange chromatography (Pharmacia Mono Q, HR-515; 
gradient elution 20 m~ HEPES, pH  7.3,  0.1-1.5 M NaC1; INF3DI  was 
eluted at 1.0 M NaCl). 
Peptide INF5-The synthesis of dimeric influenza peptide INFS was 
performed starting with 230  mg of TentaGelm  S-PHB resin (Rapp Poly- 
mere; 0.27  mmol/g) using the HBTU activation method (1 mmol scale). 
The abbreviations used are: Fmoc, N49-fluorenyUmethoxycarbony1; 
FCS, fetal calf serum; HBS,  HEPES-buffered saline (150 m~ NaCI,  20 
m HEPES, pH 7.3); pLysZw, poly(L-lysine) with an average chain 
length of 290 lysine monomers; t-Bu, tert-butyl; TEAB, triethylammo- 
nium bicarbonate; TfpLys, transferrin-poly(L-lysine) conjugate; T r t ,  tri- 
tyl; HPLC, high performance liquid chromatography; DMEM,  Dulbec- 
co’s modified Eagle’s medium; FITC, fluorescein isothiocyanate; HA, 
hemagglutinin. 
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Gene Dansfer Enhanced by Endosomolytic  Peptides 12919 
The  first  amino acid to be coupled was  N"p-di-Fmoc-lysine.  This  re- 
sults  in  the  synthesis of a peptide-head-to-head-dimer  with a carboxyl- 
terminal  lysine as linking  amino  acid. 
Peptides GALA,  GALA-GLE: GALA-INFl, and GALA-INF3-The 
Cys-t-Bu protected  peptide GALA was dissolved in  100 m~ TEAB and 
further purified  on a Nucleosil 5OC5C4 column (0.1% aqueous  triflu- 
oroacetic  acid,  gradient of 0% to 80% acetonitrile).  The  peptide  eluted at 
about 50% acetonitrile.  The  crude  mercapto  form of peptide GALA (5 
mg, obtained by deprotecting  the  corresponding  Trt-Cys  peptide)  was 
dissolved in  100 pl of 100 m~ TEAB, pH 8, containing 1 pl of &mer- 
captoethanol and purified by gel filtration (Sephadex G-10, 100 m~ 
TEAB, 0.5 mM EDTA) and ion exchange  chromatography (Mono Q Phar- 
macia, buffer A 20 m~ HEPES,  pH 7.3; buffer B: A plus 3 M NaCl; 
gradient elution 0-100% B; the peptide was eluted a t  1.5 M NaCI). 
Peptides GLF GALA-INF1 and GALA-INF3 were synthesized in   an 
analogous  manner. 
The purity of the peptides was determined by analytical reverse 
phase  HPLC, and peptide  identities  were confirmed by time-of-flight 
mass  spectrometry  (14)  performed  with  a  a  Finnigan MAT Lasermat 
instrument.  Purified  peptides  were  stored at -80 "C as a lyophilized 
powder  or  in 40% glycerol. Peptides  INF1,  INF6,  and  INF7  lost  their 
biological activity when stored in solution, most likely by structural 
changes  involving  aggregation  (changes in HPLC profile). The  amount 
of mercapto  groups in  peptides  was  determined  using  5,5'-dithiobis(2- 
nitrobenzoic  acid) and  measurement at 412 nm  (13).  When monomeric 
forms of peptides were used in subsequent experiments, mercapto 
groups  were blocked by reaction  with 1.3 to 5 eq of N-(hydroxyethy1)- 
maleimide (1 h, room temperature).  Excess  maleimide  was  removed by 
gel filtration  (Sephadex G-25, 100 m~ TEAB, pH 8). 
Liposome  Leakage Assay 
Liposomes were  prepared from egg  phosphatidylcholine  (Avanti Po- 
lar Lipids) by reverse  phase  evaporation (15) with an  aqueous  phase of 
100 m calcein  (dissolved by addition of 3.75  eq of sodium  hydroxide) 
and 50 m~ NaCl,  extruded  through a 100-nm  polycarbonate  filter  (16) 
and purified by gel filtration on Sephadex G-25 with an  iso-osmotic 
buffer (200 m~ NaCl, 25 I" HEPES, pH 7.3). The liposome stock 
solution  was  diluted  to  a lipid concentration of 45 p~ in  1.8 x assay 
buffer  (360 m~ NaCI, 36 mM sodium  citrate of appropriate  pH).  A  serial 
dilution of the  test  peptide  in  water  (highest  concentration: 5-20  pg/lOO 
pl; dilution  steps of 15) was  prepared  in  a 96-well microtiter  plate by 
transferring  20  pl of the peptide  solution from one well to  the  next well 
and  diluting  with  80 pl of  H,O. An aliquot of 100  pl of liposome solution 
was  added  to  80  pl of the  dilutions of peptides  (final lipid concentration: 
25 p ~ )  and,  after  30  min at room temperature,  was  assayed for fluores- 
cence a t  515 nm (excitation  495  nm) on a microtiter  plate  fluorescence 
spectrometer (Perkin-Elmer Cetus). The value for 100% leakage  was 
obtained by addition of 1 pl of a 10% Triton X-100 solution. Sigmoid 
curves of leakage  activity as  a  function of the peptide  concentration 
were  obtained.  The  leakage  units  were  calculated  as  reciprocal  values of 
the peptide concentration, where 50% leakage was observed (i.e. the 
volume (111)  of liposome solution,  which is 50% lysed,  per  pg of peptide). 
Erythrocyte  Lysis Assay 
Freshly  prepared  human  erythrocytes  were  washed  with  HBS  and 
resuspended  in a 2 x assay  buffer of the  appropriate  pH  (300 m~ NaCI, 
30 m sodium  citrate) at a concentration of approximately  7 x lO'/ml. 
An aliquot of 75 pl was  added  to  75 p1  of a  serial  dilution of the peptide 
in  water  in a 96-well microtiter  plate  and  incubated for 1 h at 37 "C with 
constant  shaking.  After  removal of the unlysed  erythrocytes by centrifu- 
gation  (1000 x g, 5 min),  100 pl of the  supernatant  were  transferred  to 
a new microtiter  plate,  and hemoglobin absorption  was  determined at 
450 nm (background  correction at  750 nm).  100%  lysis  was  determined 
by adding 1 p1 of a 10% Triton X-100 solution  prior  to  centrifugation. 
The  hemolytic  units  were  calculated as the reciprocal  value of the pep- 
tide  concentration,  where 50% leakage  was observed (i.e. the volume 
(pl) of erythrocyte  solution  which is 50% lysed,  per  pg of peptide). 
Fluorescence Microscopy 
71,200 (Sigma  FD-70s)  was dissolved in DMEM (Life Technologies Inc.) 
Fluorescein isothiocyanate dextran of average molecular weight 
and subjected to gel filtration  (Sephadex G-25 PD-10; DMEM) to  re- 
move low molecular  weight  components. BNL C1.2 cells  were  split  into 
Lab-Tek chamber  slides  (Nunc  177402) at a  density of 10,000 cells per 
well and grown  overnight  in DMEM plus 10% FCS.  The  medium  was 
removed,  and  150  pl of DMEM containing 5 mg/ml FITC  dextran  and 
0.5 mg/ml peptide  INF3DI or INF4DI  was  added.  Cells  were  incubated 
a t  37 "C for 15 min.  The  incubation  medium  was removed and  the cells 
were  incubated  in  fresh DMEM plus 10% FCS for an  additional 15 min 
at 37 "C. The  cells  were fixed in  phosphate-buffered  saline  containing 
3%p-formaldehyde for 3 min,  air-dried,  and  mounted  with  coverslips  in 
Mowiolm. Fluorescence microscopy was  performed  with  a Zeiss Axio- 
phot microscope using a CCD camera (Photometrics, Tucson, AZ). 
Where  indicated,  cells  were  preincubated  with 200 nM bafilomycin A, 
(Sigma B-8281, 200 x stock  solution in  dimethyl  sulfoxide)  in DMEM 
plus 10% FCS for 30  min.  Subsequent  steps  were as  described above, 
with  the  exception  that  the  medium  always  contained 200 I" bafilomy- 
cin. 
Pansfeetion  of Cells 
BNL C1.2 hepatocytes were grown in DMEM with 10% FCS, 100 
unitdml penicillin,  100 pg/ml streptomycin, and 2 m glutamine,  plated 
at a density of 300,000 cells  per 6-cm dish  or 100,000 cells  per 3-cm dish 
or per well of a 6-well plate.  The  medium  was  replaced by 500 pl of  DNA 
transfection complexes mixed with  1.5  ml or 0.5  ml  (when  using 6-cm or 
3-cm dishes,  respectively) of medium  plus  FCS. After 4  h at  37 "C, the 
transfection  medium  was  replaced by 4  ml  (or  2  ml) of DMEM with 10% 
FCS. Harvesting of cells and luciferase assays were performed 24 h 
after  transfection  as  described  (3).  The  light  unit  values  shown  in  the 
figures  represent  the  total  luciferase  activity of the  transfected cells. A 
standard of 2  ng of luciferase  (Sigma L-5256) corresponds  to lo6 light 
units. 
Biospecific Interaction Analysis 
The interaction between peptide GALA-INF3 and polylysine was 
examined  using  a  surface  plasmon  resonance  detection  system (BIA- 
coreTM, Pharmacia).  Changes of mass on the  sensor  surface (a gold film 
coated  with a layer of carboxymethyl-dextran)  correlate  with  changes of 
an optical  signal  presented as resonance  units.  The carboxyl groups at 
the sensor surface were activated by injecting 50 p1 of an  aqueous 
solution  containing  0.25 M N-hydroxysuccinimide  and 1 M N-ethyl-N" 
(dimethylaminopropy1)carbodiimide a t  a flow rate of 5 $min. The N- 
hydroxysuccinimide-ester intermediates  were  reacted  with  cysteamine 
(50 pl of a 4 M solution in HBS, flow rate 5 pl/min) to  introduce  mercapto 
groups on the surface.  The  activation  procedure  was  repeated five times 
in  order to  minimize unmodified carboxyl groups. Finally, nonreacted 
N-hydroxysuccinimide  esters  were blocked with 1 M aqueous  ethanola- 
mine  hydrochloride,  pH 8.5. 
For  interaction  analysis,  both  the  mercapto  surface  and, as control, 
an  unmodified surface  were  used.  Response  units  are  listed  in Table 11. 
The  sensor  surface  (report  point i) was  rinsed  with pLysZw (10  ng/pl  in 
HBS, flow rate 1 pl/min) to  detect  the  levels of unspecific binding  (report 
point  ii).  Then, ionically bound polylysine was  removed by washing  with 
1.5 M NaCl  (report  point iii, in HBS).  The  surface  was  treated  with  a 1 
M solution of dithiothreitol followed by HBS. For  coupling the peptide 
GALA-INF3, 35 pl of 0.5 mg/ml peptide (thiopyridine form) were in- 
jected  (report  point  iv), followed by three  washes  with  1.5 M NaCl  and 
HBS  (report  point 1). Again, pLysZw in  HBS  was  injected  to  observe  the 
formation of the ionic complex with  the  surface-bound  peptide or the 
control  surface. Loosely bound polylysine was  washed  away  with  HBS, 
pH  7.3  (report  point  2). To examine  the  behavior of the peptide-polyly- 
sine complex at  acid pH, the sensor was washed with CBS (citrate- 
buffered  saline,  150 m NaC1, 15 m~ sodium  citrate buffer, pH 5; report 
point  3).  Full  dissociation of complexed polylysine was observed after 
washes  with  1.5 M NaCl followed by HBS  (report  point  4). 
RESULTS 
Starting from the  amino-terminal fusogenic peptide se- 
quence of influenza hemagglutinin  subunit HA-2 (Fig. l.4 ), we 
have synthesized a series of amphipathic peptides (see Table I) 
and  tested  their  membrane  disruption activity in liposome and 
erythrocyte leakage assays (Fig. 1, B and C). Peptide INFl 
containing the 20 amino-terminal amino acid sequence of  HA-2 
shows a 10-fold increased liposome leakage activity at  pH 5 
compared to pH 7. Peptides INF2 (glycine to glutamic acid 
substitution at position 4) or INF3,  INF4 (glycine, alanine  to 
glutamic acid substitutions at positions 4 and 7) have even 
higher  pH specificity with  leakage activity  detectable only at 
the lower pH. This  is consistent with  data of analogous  peptides 
(7, 17, 18) and with the model that  additional glutamic  acids at 
positions 4 and 7  (jointly with  the acidic residues at positions 
11, 15, and 19) should further destabilize an a-helix at neutral 
pH  (see Fig. lA). Surprisingly, in  the erythrocyte lysis assay, 
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A B C 
pH 7 PH 5 Leakage Units (pVllg) Hemolytic Units ()I!&) 
FIG.  1. Amino-terminal  fusogenic  peptide of influenza  hemagglutinin  subunit HA-2 and  synthetic  derivatives. A, conformation at 
neutral pH,  according to data from x-ray analysis (50,51) and a-helical conformation at low  pH, consistent with Refs. 18 and 52. B,  leakage assays 
using phosphatidylcholine liposomes. C ,  erythrocyte lysis assays. Assays at pH 7 and pH 5 were  performed as described under "Experimental 
Procedures." 
TABLE I
Sequences of peptides 
Influ HA2, amino-terminal sequence of influenza virus X-31 (H3N2) hemagglutinin subunit HA-2; INFl and INF2 are described in Ref. 7; GALA, 
analogous to peptide sequence reported in Refs. 19-21; mp, 3-mercaptopropionic acid; n, norleucine; C-C or CC], cysteine disulfide bond; IK, 
carboxyl-terminal lysine  modified at N" and N'. 
Influ HA2 
INFl 
INF2 
INF3 
INF3DI 
INF3DI2 
INF3DI3 
INF4 
INF5 
INF6 
INF7 
GALA 
GALA-GLF 
GALA-INF1 
GALA-INF3 
GLF GAI AGFI  ENGW  EGMI 
GLF GAI AGFI  ENGW  EGMI 
GLF EA1  AGFI  ENGW  EGMI 
GLF EA1  EGFI  ENGW  EGMI 
GLF  EA1  EGFI  ENGW  EGMI 
GLF EA1  EGFI  ENGW  EGMI 
GLF EA1  EGFI  ENGW  EGMI 
GLF EA1  EGFI  ENGW  EGMI 
GLF EA1  EGFI  ENGW  EGMI 
GLF EA1  EGFI  ENGW  EGMI 
GLF EA1  EGFI  ENGW  EGnI 
GLF EA1  EGFI  ENGW  EGnI 
GLF EA1  EGFI  ENGW  EGnI 
GLF GAI AGFI  ENGW  EGMI 
GLF EA1  EGFI  ENGW  EGMI 
WEA  ALA  EALA  EALA  EHLA 
GLFG ALA  EALA  EALA  EHLA 
GLF GAI AGFI  ENGW  EGLA 
GLF  EA1  EGFI  ENGW  EGLA 
DGWYG- ~ - - 
DGGGC 
DGGGC 
DGGGC 
DGGGC 1 DGGGC 
DGGGC-mpGG 
DGGGC  -mpGG 
DGGGC-mpGGG 
DGGGC-mpGGG IK 
DGCA 
DGWYG 
DGWYG 
E LA  EALEALAAGGSC 
EALA  EALEALAAGGSC 
EALA  EALEALAAGGSC 
EALA  EALEALAAGGSC 
none of the peptides INF1-INF4 showed significant activity. 
The liposome preparations  and erythrocytes differ in lipid com- 
position, membrane surface charge,  and modification; erythro- 
cyte membranes  contain negatively  charged,  sialic acid-modi- 
fied glycoproteins and may be less accessible to  the peptides. 
Dimerization of the influenza  peptides either by disulfide bond 
formation at the carboxyl-terminal  cysteines (INFBDI, INFSDI, 
INF4DI) or by direct  synthesis of the dimer starting from a 
carboxyl-terminal branching lysine (INF5)  resulted  in  an  ap- 
proximately 20-fold enhanced liposome leakage activity and 
high, pH-specific lysis of erythrocytes. Another acidic am- 
phipathic peptide, GALA, designed by the group of Frank 
Szoka (19-21), showed an even higher, pH-specific liposome 
leakage activity. Peptide GALA-GLF, which contains  the  three 
amino-terminal amino  acids of influenza HA-2, has  the highest 
liposome leakage activity. These two peptides, however, have a 
500-fold lower erythrocyte  lysis  activity than  the influenza pep- 
tide dimers. Peptides GALA-INF1 and GALA-INF3 were de- 
signed by replacing the  first 16  amino  acids of  GALA with the 
amino-terminal sequence either of INFl (influenza wild type) 
or of INF3. This elongation of the influenza  sequences yields 
peptides with pH specificities similar to the short influenza 
sequences INFl or INF3, but also  with  erythrocyte  lysis  activi- 
ties  nearly as high as  the dimeric  influenza  peptides. Peptides 
INF6  and INF7 containing  the sequence of the 23  amino-ter- 
minal  amino  acids of  HA-2 show the  highest erythrocyte lysis 
activity. When compared to peptide INFl or INF3, the  small 
elongation  including the hydrophobic residues Trp and Tyr at 
the carboxyl terminus of INF6 or INF7 results  in a surprising 
(>lOOO-fold) increase in activity. Melittin (22), a peptide of 
known high, but  not pH-specific, activity, was included in  the 
assays  as  standard. 
The capacity of peptides to  disrupt endosomes was tested by 
incubating  cultured cells (BNL C1.2 hepatocytes or NIH  3T3 
cells) with medium  containing high molecular weight (70,000) 
FITC-dextran with or without peptide (INF3D1, INF4D1, or 
GALA-INF3) for 15 min at 37 "C,  followed  by a 15-min  incuba- 
tion with  normal medium.  FITC-dextran,  when taken  up  into 
cells by fluid phase endocytosis, accumulates  in  internal 
vesicles that  appear as bright  spots (Fig. 2a)  in fluorescence 
microscopy. When an endosomolytic peptide is included in  the 
culture medium, no bright vesicles were found in most areas of 
the cell culture slide, and  the fluorescence was spread over the 
cell indicating  that  the FITC-dextran had been released into 
the cytoplasm (Fig. 2, b and d) .  The presence of bafilomycin, an 
inhibitor of vacuolar ATPases (23) which specifically blocks the 
endosomal  proton  pump,  also blocked the peptide-mediated  re- 
lease of FITC-dextran from internal vesicles (Fig. 2c). 
A modified version of gene transfer complexes was generated 
that  contains  the  membrane-disruptive peptides ionically 
bound (Fig. 3a). Half of the negative charge of the plasmid DNA 
encoding a luciferase reporter gene  was saturated  with  trans- 
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1 
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" _1 
F'IG. 2. Peptide-mediated release of 70-kDa FITC-dextran  from 
endosomes. Internalized FITC-dextran without ( a )  or with peptide 
INF3DI ( b )  or INF4DI (d ) ;  with peptide INF4DI and bafilomycin ( c ) .  
femn-polylysine to provide a ligand for receptor-mediated en- 
docytosis. The  remaining nucleic acid charge  was  utilized for 
binding an excess of polylysine. The binding of excess poly- 
lysine is kinetically controlled; these complexes are  not formed 
when  electroneutral,  polylysine-saturated DNA complexes 
have been provided with an excess of polylysine.' To the posi- 
tively charged DNA complex, the negatively charged  peptide 
was added to provide the endosome disrupting activity  (Fig. 
3a). These complexes were  added to cell culture medium and 
incubated with BNL C1.2 cells. A strong correlation of gene 
transfer efficiency (see Fig. 3b)  with  the capacity of peptides to 
lyse erythrocytes in  an acidic environment  was found. Using 
the dimeric  influenza  peptides INF3D1, INF4DI  (Fig. 3d),  INF5 
(see Fig. 61, or monomeric peptide INF7  (data  not shown), high- 
est gene  expression levels (more than 5000-fold higher  than  in 
the absence of peptide) were obtained. Peptides GALA-INF3 
and GALA also mediate gene transfer, with an approximately 
2-fold or 20-fold lower efficiency. Monomeric influenza  peptides 
INF3 (or INF2, INF4, not shown) do not significantly enhance 
gene  transfer.  Peptides that possess a high hemolytic potential 
but do not display the  strong specificity for low pH (GALA- 
INF1, melittin; or INF6, not shown) or lack the negative 
charges necessary for binding to the DNA-complex (melittin) 
show only moderate to insignificant augmentation of gene ex- 
pression. Introduction of spacer sequences between the two 
coupled influenza  peptides INF3 gradually  decreases the activ- 
ity of the dimeric  peptides  (INF3DI2, INF3DI3) both in  eryth- 
rocyte membrane disruption and gene transfer to BNL C1.2 
cells (Fig. 3c). Inhibition of the endosomal acidification by 
blocking the endosomal proton pump  with bafilomycin also con- 
siderably  reduced  peptide-mediated  gene  expression (Fig. 3d). 
The gene transfer efficiency of DNNpolylysine/peptide com- 
plexes lacking transfemn  was, on average, 8-fold lower (data 
not shown). 
Synthetic protease-resistant peptides ( D ) - W ~ D I  and (D)- 
INF3DI  consisting of (Dl-amino acids showed leakage  activities 
indistinguishable from their  counterparts synthesized from (L)- 
amino  acids (data  not shown). In  order to test whether degra- 
dation in lysosomal compartments influences the gene transfer 
process, DNA complexes containing (L)-PLYS or (D)-PLYS and 
(L)-INF~DI or (D)-INF~DI were  assembled and applied to cul- 
tured cells (Fig. 4). The transfection efficiencies did not signifi- 
cantly  change  when the metabolically more stable (Dbpeptide 
and (D)-polylysine were used. 
C. Plank, B. Oberhauser, K. Mechtler, C. Koch, and E. Wagner, 
unpublished observation. 
Ionic binding of peptides to polylysine modifies their behav- 
ior in  membrane disruption (see Fig. 5A). Electroneutral mix- 
tures of GALA-INF3 and polylysine showed a lower erythrocyte 
lysis activity  (approximately %fold lower than peptide alone). 
Furthermore, at  this  ratio, precipitates were formed (see Fig. 
5B).  During  the  first  hour of most  gene transfer experiments 
described in Fig. 3 also a slow formation of up to 1 1.1~ large 
precipitates,  consisting of  DNA and polylysine, was observed. 
To determine  whether  the precipitates or soluble complexes are 
the active components in gene transfer, transfection complexes 
were fractionated by centrifugation into a metrizamide cushion 
containing the precipitates and a supernatant fraction contain- 
ing soluble complexes; the transfection efficiency with the 
soluble fraction was 20-fold higher  than with the precipitate 
fraction.' Next, we analyzed the association of polylysine and 
peptide GALA-INF3 by using a surface plasmon resonance de- 
tector  (24) and asked whether  the ionic complexes dissociate at 
acidic pH, when the peptide is protonated.  Peptide GALA-INF3 
was bound covalently to a sensor modified with carboxymethyl- 
dextran. Care was taken  that carboxymethyl groups, which 
also may ionically interact with polylysine, were blocked by 
modification with  ethanolamine. Polylysine injected through a 
microflow cell was bound to the peptide-coated sensor surface, 
resulting  in a change of an optical signal  (see Table 11). Poly- 
lysine  remained bound when washed  with neutral, physiologi- 
cal 150 mM salt buffer, whereas  about half of the polylysine was 
eluted by an acidic 150 mM salt buffer, pH 5. Residual poly- 
lysine  was  released by washing with  high salt buffer. 
Polylysine-rich, positively charged DNA complexes can be 
used in transfection of cell lines but show toxic effects in pri- 
mary cells.' For gene transfer to primary  human melanoma 
cells (Fig. 6), we generated less  charged  transfection complexes 
by using two alternative  strategies. Firstly, biotinylated, mo- 
nomeric peptide INF3-biotin was incorporated into a transfec- 
tion complex via streptavidin-biotin  interaction  using a com- 
plex of  DNA with TfpLys and streptavidin-pLys. Alternatively, 
transfection complexes with saturating  amounts of ionically 
bound peptides were used.  Using  peptide INF5 at a peptide: 
polylysine charge  ratio of approximately 4:1, no precipitates 
were formed during transfection, and high expression levels of 
the luciferase reporter gene  (Fig. 6 A )  or a human interleukin-2 
gene (Fig. 6B) were observed. Using peptide INF6 (low pH 
specificity) or INF7  (high specificity for  low pH)  in  an alogous 
experiment, 2% or 70% of the luciferase expression with  INF5 
was obtained. 
DISCUSSION 
Membrane fusion, membrane disruption, or the formation of 
transmembrane  channels  are  essential  steps of many biological 
processes (25,26)  such as the fusion of cells (271, ofvesicles (28), 
or the sperm-egg fusion (29). These processes are also involved 
in  the  entry of viruses (30-34) and microorganisms (35,36) into 
cells, in  the cytolytic action of toxins of microorganisms (37,38), 
defense toxins of insects (22, 39), or fish (40), in  the immune 
system  (41,421, and  the action of antibiotic  peptides of insects 
(43), frogs (44), or vertebrates (45). The membrane-reorganiz- 
ing activity often can be assigned to a short fusion domain of 
about 30 amino acids  containing an  alternating  pattern of hy- 
drophobic domains (about 1-3 amino  acids) interrupted by hy- 
drophilic domains. Under  appropriate conditions, most of these 
fusion peptides are expected to form amphipathic a-helices that 
can  interact with  lipid  membranes. In  the case of several vi- 
ruses that enter cells via endocytosis, this conformational 
change of the fusion domain is triggered by the low pH within 
the endosomes. Most acid-triggered fusion peptides contain 
acidic amino  acids  within their hydrophilic domains, whereas 
pH-insensitive  peptides have no acidic residues andor a pref- 
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FIG. 3. Transfection of BNL C1.2 
hepatocytes. a, assembly of quaternaly 
gene  transfer complexes containing  pep- 
tides ionically bound to polylysine. b, 
DNA complexes were  prepared by mixing 
6 pg of pCMVL-DNA in 250 p1 of HBS 
with 4 pg of TfpLysZgo in 250 p1  of HBS, 
followed by mixing  with 20 pg of in 
750 pl of HBS  and  optimized  amounts of 
peptides  (30  pg of INF3,  30 pg of INF3D1, 
of GALA-GLF, 10 pg of GALA-INF1, or 3 
pg of melittin) in  250 pl of HBS. All mix- 
ing  steps  were  performed a t  30-min  inter- 
vals. After an  incubation  for  another  30 
min, complexes were  mixed  with 0.5 ml of 
DMEM plus 6% FCS  and  added to 
300,000 cells. Harvesting of cells  and  lu- 
ciferase  assays  were  performed as  de- 
scribed  under  “Experimental Proce- 
dures.” c, erythrocyte  leakage  activity of 
dimeric  peptides INF3D1, INF3DI2, or 
INF3DI3  and  gene  transfer efficiencies of 
d ,  inhibition of gene  transfer by 200 I” 
corresponding complexes in 300,000 cells. 
bafilomycin (100,000 BNL C1.2 cells; com- 
plexes consisted of 6 pg of pCMVL, 3 pg of 
TfpLyszg”, 10 pg of pLysm, and  30 pg of 
peptide  INF5). 
20  pg of GALA-INF3,20  pg of  GALA, 4 pg 
(b) Luciferase  Activity  (Light Units) 
3 4 5 6 7 8  
no peptid‘k-1 
10 10 
INF3 
INF301 
GALA- INF3 
G A L A  
G A L A - G L F  
GALA- INF1 
MELITTIN 
(c) Erythrocyte  Leakage  Transfection  Effiency (d) Inhibition  by  Bafilomycin 
I 
1 
(L) P L Y ~  (0) P L Y ~  
FIG. 4. Use  of  the  metabolically  stable  peptide a l l - ( o ) - m 3 D I  
consisting of  (nbamino acids. Transfection efficiencies of complexes 
containing 6 pg of pCMVL-DNA, 4 pg of TfpLysZW, 10 pg of  (L)-pLysZ” or 
(D)-PLYS~~,   and 30  pg of (L)-INF~DI or (D)-INF~DI,  using 100,000 BNL 
C1.2 cells cultured in 6-well plates. Left bar, no peptide; center bar, 
(LbINF3DI; right bar, (DbINF3DI. 
erence for  positively charged  residue^.^ 
One carefully studied fusogenic protein is  the trimeric influ- 
enza virus hemagglutinin (HA). Endosomal  acidification trig- 
gers a  structural change which  exposes the fusion peptide do- 
main located at the amino terminus of the  subunit HA-2 (31, 
46). Within the fusion peptide, the repulsions of negatively 
charged acidic side chains (at positions 11,15,  and 19) prevent 
the formation of an a-helix at neutral pH (Fig. lA, left) .  In  the 
endosome,  upon protonation of the carboxyl groups, the fusion 
peptide is thought to adopt an a-helical conformation (Fig. l A ,  
right). The amphipathic helices of the virus penetrate the en- 
dosomal membrane of the host cell,  which finally leads to fusion 
of the viral membrane with the endosomal membrane. Syn- 
thetic peptides containing 16 to 20 amino acids of the influenza 
HA-2 amino terminus have been reported (17,181 to fuse phos- 
phatidylcholine liposomes and also cause leakage of aqueous 
liposomal contents at pH values lower than 6. 
Our use of similar synthetic peptides as endosome-disrupt- 
ing agents in gene transfer has already been described (7, 8). 
The surprising inability of HA-2-related peptides INF1-INF4 
to release hemoglobin  from erythrocytes prompted us to con- 
struct dimers of these peptides (INFSDI, INF4DI and INF51, to 
B. Oberhauser, C. Plank,  and E. Wagner, manuscript  in  preparation. 
1 
FIG. 5.Erythrocyteleakageactivitydependsonratioofpeptide: 
polylysine. Solutions of indicated  amounts of pLysZW (0-6.8 pg)  in 50 
p1  of 150 m~ NaCl  were mixed with 5 pg of GALA-INF3 in 50 pl of 150 
m NaCl and  incubated for 30  min at room temperature  in a 96-well 
microtiter  plate. Two wells were  filled  with 5 pg of polylysine in 100 pl 
of 150 m~ NaCl  without  peptide. A,  erythrocyte  lysis  assays  were  per- 
formed by the  addition of 75 pl of erythrocytes in  150 m NaCl  and 
sodium  citrate buffer, pH 7.0  or pH 5.0, to  each well. B ,  mixtures of 
GALA-INF3 and polylysine were  prepared  as  described above, diluted 
with 200 p1 of 150 m NaCl, and used for turbidity measurement 
(absorbance a t  600  nm). 
mirror the manner in which these peptides are presented by 
the virus (46). These dimers showed enhanced liposome leak- 
age activity and, most important,  a high and pH-specific activ- 
ity in erythrocyte lysis (Fig. 1C). It appears that  the enhanced 
erythrocyte leakage activity observed with dimeric peptides is 
due to the elongated a-helix of the dimer, rather  than to the 
cooperative interaction of the monomers. Introduction of a non- 
helical spacer sequence between the two fusion sequences 
(INF3DI3) strongly reduced erythrocyte lysis activity; peptides 
GALA-INF1 and GALA-INF3, containing the 16 amino-termi- 
nal HA-2 residues elongated with 14 amino acids of an artificial 
amphipathic sequence (19), have erythrocyte lysis activity 
nearly as high as  the dimeric influenza peptides. 
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TABLE I1 
Interaction  analysis  response  units 
Merca to surface 
Report points ( E D C ~ ~  cysteamine)" (carbxymethyl dextran) 
Control surface 
Relative RU ARU Relative RU ARU 
i HBS 0 0 
ii pLys 646  646 2446 
iii NaCI,  HBS 22 
iv GALA-INF3 
-624 
6669 
-2 
6647 6 
1 NaCI, HBS 6430 -239 4 
2 pLys,  HBS 8393 1963 2466 
3 CBS,*pH5 7653 -740 2759 
4 NaCl, HBS 6375 -1278 32 
a EDC, l-ethyl-3-(3-dimethylaminopropyl)carbodimide; 
* CBS, citrate-buffered saline. 
nance units. 
(A) Luaferase  activity  (L ght units) 
lo4 l o 5  l o 6  10' l o 8  l o 9  
lNFIDl(10 pg) 
INFIDI (40 p g )  
INF5 (40 pg) 
INFI-biotin 
(B)  Interleukin-2  Expression 
l o 3  10 l o 5  
(Units I 24 hts H O  mls) 
Days 
2 1 1500 I 
2446 
-2448 
8 
-2 
2462 
293 
-2727 
RU; reso- 
FIG. 6. Gene transfer to human melanoma cells. A, luciferase 
expression. Transfection complexes with peptides ionically bound to 
polylysine (3 pg of pCMvL, 1.5 pg of TfpLysZw, 5 pg of  pLysZw, 10 pg of 
INF3DI or 40 pg of INWDI, or INF5) or peptides bound through a 
biotin-streptavidin interaction (3 pg of  pCMVL, 1.5 pg of TfpLysZw, 3 pg 
of  streptavidin-pLysz", 10 pg of INF3-biotin) were used. DNA complexes 
were mixed with 0.5 ml of  RPMI 1640 (Life Technologies, Inc.) contain- 
ing 10% FCS, and added to human melanoma cells (100,000 cells in 
6-well plates). After 4 h, the medium was replaced by fresh medium. 
The cells were harvested 24 h after transfection and assayed for lucif- 
erase activity. E ,  expression of human interleukin-2 (IL-2). Transfection 
complexes of 3 pg of  pGShIL-atetr, 1.5 pg of TfpLysZw, 5 pg of  pLys2", 
and 40 pg of INF5  were  applied as described in A. At  day 1 and day 2 
after transfection, the amounts of interleukin-2 secreted into the cul- 
ture medium within 24 h were determined by an enzyme-linked immu- 
nosorbent assay (Biokinem IL-2 test  kit, T Cell Diagnostics, Cambridge, 
MA). Values are given in BRMP units per million cells; 1 BRMP unit is 
equal to 40 pg  of IL-2. 
In  the  light of these  results, we re-examined the HA-2 se- 
quence and suspected that  the  aromatic  residues Trp-21 and 
Tyr-22, which are  not included in  the  synthetic peptides we and 
others (17, 18) used,  might play an  important role in  the  inter- 
action with  the lipid membrane. To test  this notion, peptides 
INFG, consisting of the 23 residues of the fusion peptide, and  an 
acidic mutant thereof, INF7, were synthesized. The  small 
changes  in  the monomeric peptides (substitution of Gly-Gly in 
INFl  and  INF3, for Trp-Tyr) resulted  in a dramatic change in 
membrane  disruption behavior, yielding the  highest  erythro- 
cyte  lysis  activity of all  investigated peptides. 
The  importance of the  free  amino  terminus  (Ha-Gly-Leu- 
Phe)  in  membrane destabilization as reported  in Refs. 17  and 
47 prompted our investigation of the membrane-disruptive 
abilities of the  synthetic GALA peptide (19-211, elongated by 
these residues.  A marked synergism of Gly-Leu-Phe with the 
GALA sequence was found; the designed  peptide GALA-GLF 
shows the  highest  and pH-specific liposome leakage activity. 
However, peptides GALA-GLF and GALA have  far lower eryth- 
rocyte lysis  activity than  the most effective influenza  peptides. 
The  contrasting behavior of GALA (and GALA-GLF) in lipo- 
some and  erythrocyte  leakage may be explained by the findings 
of Parente et al. (21) that GALA forms small channels and 
mediates  the  release of small molecules (such as calcein) but 
not  larger molecules (such as hemoglobin). 
The ability of the peptides to  disrupt endosomes of cultured 
cells and  release co-internalized compounds to the cytoplasm 
has been examined by the  release of fluorescent compounds. 
Upon fluid phase pinocytotic uptake of peptides INF3DI or 
INF4DI  with  FITC-dextran, the fluorescent matter was shown 
to be released  (Fig. 2). The low molecular  weight fluorophore 
calcein was similarly  released (data  not shown). The  release  is 
inhibited by bafilomycin, which specifically blocks the endoso- 
mal proton pump  and, consequently, the acidification of endo- 
somes. The efficiency of endosome disruption  is strongly de- 
pendent on a high  concentration of membrane-active  peptide. 
At a  concentration of approximately 100 1.1~ peptide, the  ma- 
jority of endocytic vesicles were disrupted  within 15-30 min; at 
3-fold lower concentration, no significant leakage  was  detecta- 
ble by fluorescence microscopy. The findings of endosomal re- 
lease  were further confirmed (53)  in  experiments in oitro by the 
peptide- and pH-dependent release of biotin-dextran from en- 
dosomes that  had been isolated from cells incubated with bio- 
tin-dextran, peptide GALA-INF3, and ammonium chloride. 
These  experiments also  revealed that a  10-kDa dextran  is more 
readily  released than a 70-kDa dextran. 
For us, a major  incentive to  study  the endosome-disruptive 
properties of fusion  peptides has been their potential  applica- 
bility in  synthetic, virus-like  gene transfer systems.  Supplying 
unconjugated monomeric influenza  peptides INFl or INF2 (7), 
but also the more potent peptides INFSDI, INF5, or GALA- 
INF3  (data  not shown) to  the transfection  medium  containing 
transferrin-polylysine/DNA complexes does not considerably 
enhance gene transfer. We believe that  the peptide-mediated 
release of (2100 nm)  large DNA complexes from endosomes is 
a less frequent  event  than  the  release of small compounds and, 
as the peptides disrupt  membranes  in a highly concentration- 
dependent  manner,  requires  strategies  that concentrate  mem- 
brane-destabilizing peptides in sufficient quantities  and active 
form into  the vesicles containing the DNA to be delivered. Our 
first synthetic, virus-like gene transfer complexes with en- 
hanced activity  contained polylysine-conjugated influenza pep- 
tides  INFl or INF2 (7). It was fortuitous  that  the modification 
of these monomeric influenza  peptides  with polylysine not only 
provided DNA-binding property, but also substantially en- 
hanced the  membrane  disruption activity. The  numbers of pep- 
tides  per DNA complex were low because of technical  reasons; 
the transfection efficiency, however, was found to  correlate with 
an  increasing  number of peptides  linked to polylysine. For this 
reason, a new, more efficient version of gene transfer complexes 
was  generated  that  contains  up  to 10-fold larger  amounts of 
negatively  charged,  membrane-disruptive  peptides ionically 
bound to polylysine (see Fig. 3). Luciferase  gene transfer effi- 
ciency in BNL C1.2 hepatocytes strongly correlates with the 
capacity of peptides to lyse erythrocytes specifically under 
acidic conditions. INF3DI-mediated  gene transfer  to BNL C1.2 
cells resulted  in approximately 10-fold higher expression levels 
(approximately 35 light  units  per cell) than were  obtained  with 
polylysine-conjugated influenza  peptides  (7, 8). When the  en- 
dosomal acidification was inhibited  with bafilomycin, peptide- 
mediated gene expression  was  considerably  reduced (Fig. 3d). 
The physical nature of the DNA complexes considerably in- 
fluences their biological activity. Positively charged DNA com- 
plexes containing excessive polylysine are  prepared  under ki- 
netically controlled conditions and slowly form fine  precipitates 
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12924 Gene Dansfer Enhanced by Endosomolytic  Pep des 
(21 pm  in size) with reduced  gene transfer activity. The ionic 
interaction of peptide  with polylysine also  may have a negative 
effect on membrane  disruption activity  (see Fig. 5). However, 
precipitates  during DNA complex formation can be minimized 
by applying  saturating  amounts of fusion  peptide which block 
the  charged polylysine chains.  Transfections of NIH 3T3 fibro- 
blasts or B16 melanoma cells with  these optimized DNA  com- 
plexes containing INF5  resulted  in luciferase gene expression 
levels (approximately 350 light units per 3T3 cell; approxi- 
mately  150 light  units  per B16 cell, data  not shown) consider- 
ably  higher than  those obtained with  the  same complexes in 
BNL C1.2 cells. The  importance of the  transferrin receptor in 
the endocytotic uptake of  DNA complexes varies  with cell type, 
so that  the efficiency of transfection  into BNL C1.2 cells was 
reduced %fold in  the absence of transferrin, compared to a 1.5- 
or 2-fold reduction in 3T3 or B16 cells (data not  shown). The 
absence of toxicity has also allowed the transfection of primary 
human melanoma cells with high efficiency (up  to  130  light 
units per cell; or 11,500 units of IL-2 per million cells, see Fig. 
7). 
Recently, other groups have also demonstrated the use of 
membrane-active  peptides in  enhancing DNA delivery. Midoux 
et al. (48) reported that  synthetic influenza  peptides are  able  to 
enhance receptor-mediated  gene delivery. Haensler  and Szoka 
(49) describe the  use of the GALA peptide coupled to positively 
charged polymer particles for DNA delivery. We and  others  are 
currently extending the concept of synthetic viral gene transfer 
systems (i) to the use of other membrane-destabilizing pep- 
tides, e.g. derived  from picorna viruses,  and (ii) to other ways of 
displaying these peptides in  an ordered  fashion thought  to be 
required for optimal  entry. 
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